The present disclosure generally relates to patterned microfluidic devices and methods of manufacturing patterned microfluidic devices for biomolecular analysis, and in particular, gene sequencing.
Biological samples are often complicated in composition and amount. Analysis of biomolecules in a biological sample often involves the partition of a single sample into tens of thousands or millions samples for quantitative determination. This is often achieved using a solid substrate surface to selectively immobilize and partition different biomolecules in the biological sample.
Microfluidic devices have found wide applications in biomolecular analysis, mostly driven by the ability of microfluidics to spatially and/or temporally control bio-reactions, which is critical to many biomolecular analyses. For instance, for optical-detection-based massively parallel gene sequencing techniques (also termed next-generation sequencing, NGS), millions of short DNA fragments generated from a genomic DNA sample can be captured and partitioned onto a patterned surface of a microfluidic device such that these DNA fragments are spatially separated from each other to facilitate sequencing by, for example, synthesis, ligation, or single-molecule real-time imaging. These gene sequencing techniques can be used to sequence entire genome, or small portions of the genome such as the exome or a preselected subset of genes.
Embodiments of the present disclosure represent an advancement over the state of the art with respect to microfluidic devices and methods of making the same. These and other advantages, as well as additional inventive features, will be apparent from the description provided herein.
Embodiments of the present disclosure provide a microfluidic device that contains patterned nano-wells on an etched channel floor surface for gene sequencing applications. Certain embodiments disclosed herein include a manufacturing process for making microfluidic devices that contain patterned nano-wells on an etched channel floor surface, as well as a process for using microfluidic devices, that contain patterned nano-wells on an etched channel floor surface, for gene sequencing applications.
In some embodiments, the microfluidic devices include selective surface chemistry coating of microfluidic devices that contain patterned nano-wells on an etched channel floor surface, where the interstitial wall of the nano-wells is made of metal oxide and coated with organophosphate molecules that are resistant to binding with DNA, proteins, and/or nucleotides, and the bottom surface of the nano-wells is made of SiO2 (silicon dioxide) or glass and coated with silane molecules that promote binding with DNA, proteins, and/or nucleotides via either electrostatic interaction or covalent bonds.
In some embodiments, a process of manufacturing a microfluidic device includes the steps of etching a first substrate to form at least one channel, attaching a monolayer of polymer beads onto the first substrate, reducing the size of the polymer beads using plasma etching, depositing a metal oxide film onto the first substrate over the monolayer of polymer beads, and removing the polymer beads to form an array of metal oxide nano-wells, wherein the first substrate is exposed at the bottom of the nano-wells. The process also can include depositing an organophosphate layer onto the metal oxide film, the organophosphate configured to be resistant to binding with DNA, proteins, and/or nucleotides. The method also can include depositing a silane coating layer or an acrylate polymer onto the exposed first substrate at the bottom of the nano-wells, and bonding a second substrate to the first substrate to enclose the array of metal oxide nano-wells in a cavity within the first and second substrates. The term “cavity,” as used herein, refers to the three-dimensional space bounded by the interior surfaces of the first and second substrates after bonding, while “channel” refers either to the sometimes U-shaped floor created in the first and/or second substrates, or to the individually-addressable channels formed in the aforementioned substrate floor.
In some embodiments, the method includes dispensing a solution containing the polymer beads into liquid over the submerged substrate, and transferring the polymer beads in a monolayer onto the substrate. The method may optionally include heating the substrate to cause the polymer beads to attach to the substrate, and subsequently exposing the polymer beads to oxygen plasma to reduce the size of the polymer beads. The method may further include removing the polymer beads from the substrate. For example, the polymer beads can be removed using sonication in a solvent solution such as ethanol or other solvents. Additionally, or alternatively, the polymer beads can be removed using chemical or enzymatic digestion or degradation (e.g., when the polymer beads are made of a degradable or biodegradable polymer such as polygalacturonic acid (PGA)). For example, beads made of PGA can be size reduced by plasma, and can be removed from the surface using pectinase, a plant enzyme.
In some embodiments, the method includes depositing an organophosphate layer that is one of a polyethylene glycol-containing organophosphate and/or polyvinyl phosphoric acid, (e.g., in embodiments in which the side-wall of the nano-wells formed is metal oxide). Additionally, or alternatively, the method includes depositing an organophosphate layer that is one of an amine-terminated organophosphate, epoxy-terminated organophosphate, carboxylate organophosphate, and/or an organophosphate derivative containing an unsaturated moiety such as cycloalkene, cycloalkyne, heterocycloalkene, or heterocycloalkyne (e.g., in embodiments in which the bottoms of the nano-wells are metal oxide). Further, the method may include depositing one of amine-terminated silane, epoxy-terminated silane, carboxylate-terminated silane, thiol-terminated silane, and/or a silane derivative containing an unsaturated moiety such as cycloalkene, cycloalkyne, heterocycloalkene, or heterocycloalkyne onto the exposed first substrate at the bottoms of the nano-wells, (e.g., in embodiments in which the bottoms of the nano-wells are silicon dioxide or glass). Additionally, or alternatively, the method may include depositing one of hydroxyl-terminated silane, and/or polyethylene glycol silane, (e.g., in embodiments in which the side-walls of the nano-wells are silicon dioxide).
In some embodiments, a DNA primer is covalently or otherwise bonded to the bottom of one or more nano-wells. The aforementioned polymer beads may be made from polystyrene or a similar material such as polyester, polypropylene, biodegradable polymer (e.g., polygalacturonic acid (PGA)), or another suitable material. In some embodiments, each of the polymer beads has a diameter from 0.05 micrometer to 5 micrometers. In some embodiments, the average center-to-center distance between adjacent nano-wells is from 0.05 micrometer to 5 micrometers. The substrates may include one or more individually-addressed channels in which the polymer beads are attached.
The bonding of the first and second substrates may be performed using one of a glue, a UV-curable glue, polymer tape, and pressure-sensitive tape. In alternate embodiments, bonding of the first and second substrates can be performed using laser-assisted bonding wherein a bonding layer (e.g., of metal or metal oxide) is inserted between the first and second substrates. In some embodiments, a negative charge is imparted to the polymer beads such as carboxylate-presenting polystyrene beads, and a positive charge to the substrate such as 3-aminopropyltriethoxylsilane coated glass substrate.
In some embodiments, a microfluidic device includes a first substrate with a first patterned array of nano-wells on a first interior surface and having a side wall with an end surface. In some of such embodiments, a second substrate has a second interior surface and a peripheral surface portion, and the end surface of the first substrate is bonded to the peripheral surface portion of the second substrate, such that the first and second interior surfaces define a cavity within the bonded first and second substrates.
In some embodiments, the second substrate has a second patterned array of nano-wells on the second interior surface. In some of such embodiments, the first patterned array of nano-wells or the second patterned array of nano-wells may be disposed within one or more channels in the first or second interior surface. In some embodiments, the depth of the one or more channels is from 30 micrometers (μm) to 500 micrometers (μm).
In some embodiments, the microfluidic device includes an inlet at one end of the first or second substrate, and an outlet at another end of the first or second substrate opposite the first end. The thickness of the metal oxide film may be in a range from one nanometer (nm) to 500 nanometers (nm). In certain embodiments, the metal oxide film is transparent to light with wavelengths in a range from 400 nanometers (nm) to 750 nanometers (nm).
In some embodiments, a process of manufacturing a microfluidic device includes the steps of etching a first substrate to form at least one channel, depositing a metal oxide layer onto the first substrate, attaching a monolayer of polymer beads onto the first substrate, reducing the size of the polymer beads using plasma etching, depositing a silicon dioxide film onto the first substrate over the monolayer of polymer beads, and removing the polymer beads to form an array of silicon dioxide nano-wells, wherein the metal oxide layer of the first substrate is exposed at the bottom of the nano-wells. The process also can include depositing an organophosphate layer onto the metal oxide bottom of the nano-wells, the organophosphate configured to promote the binding with DNA, proteins, and/or nucleotides. In some embodiments, the method includes depositing a silane coating layer onto the silicon dioxide side wall of the nano-wells, the silane coating configured to resist to the binding with DNA, proteins, and/or nucleotides. In some embodiments, the method includes bonding a second substrate to the first substrate to enclose the array of silicon dioxide nano-wells in a cavity within the first and second substrates.
In some embodiments, a microfluidic device includes a first substrate and an array of metal oxide or silicon dioxide nano-wells disposed on the first substrate. The first substrate can be exposed at bottoms of the nano-wells. A second substrate can be bonded to the first substrate, whereby the array of metal oxide or silicon dioxide nano-wells is enclosed in a cavity between the first and second substrates.
Additional features and advantages will be set forth in the detailed description which follows, and in part will be readily apparent to those skilled in the art from that description or recognized by practicing the embodiments as described herein, including the detailed description which follows, the claims, as well as the appended drawings.
It is to be understood that both the foregoing general description and the following detailed description are merely exemplary, and are intended to provide an overview or framework to understanding the nature and character of the claims. The accompanying drawings are included to provide a further understanding, and are incorporated in and constitute a part of this specification. The drawings illustrate one or more embodiment(s), and together with the description serve to explain principles and operation of the various embodiments.
The accompanying drawings incorporated in and forming a part of the specification illustrate several aspects of the present disclosure. In the drawings:
While certain preferred embodiments will be disclosed hereinbelow, there is no intent to be limited to those embodiments. On the contrary, the intent is to cover all alternatives, modifications and equivalents as included within the spirit and scope of the disclosure as defined by the appended claims.
Embodiments of the present disclosure are related to patterning surfaces using nanosphere lithography and, more specifically, to directly patterning the surface of microfluidic channels. Nanosphere lithography can be used to generate periodic surface nano-texturing on large area substrates such as flat glass wafers and glass sheets. In some embodiments, nanosphere lithography can be applied to make nano-patterning inside deep microfluidic channels.
Applicants have determined that patterning the surface of a solid substrate may be an effective means to selectively capture and thus partition biomolecules of interest in a biological sample. Photolithography and nanoimprinting methods may enable high throughput and high fidelity in making patterns including nano-patterning. However, such processes may be limited in the geometry of the solid substrate to be patterned. For example, photolithography may be useful for patterning flat wafer substrates (e.g., glass, pure silica, and silicon), while nanoimprinting may be useful for patterning flat or curved wafer substrates. However, it may be difficult to implement these methods for making nano-patterning inside a microfluidic channel.
Some embodiments of the disclosure described hereinbelow include microfluidic devices that contain patterned nano-wells on an etched channel floor surface, and methods of manufacturing patterned microfluidic devices for biomolecular analysis and, in particular, gene sequencing. The patterned microfluidic devices may contain one or more channels, e.g., multiple individually-addressed channels.
The channels 105 and inlet/outlet ports 120, 130 can be made on a first (top) substrate or on a second (bottom) substrate. The first substrate can be glass, glass ceramics, silica, or another suitable material, while the second substrate can be glass, glass ceramics, silicon, silica, or another suitable material. The first substrate and/or the second substrate can be transparent within the wavelength range between 400 nm and 750 nm. The patterned nano-wells 110 can be made of metal oxide, silicon dioxide, or another suitable material. For example, the patterned nano-wells can be defined within a film comprising a metal oxide, silicon dioxide, or another suitable material disposed on a first substrate and/or a second substrate (e.g., using nanosphere lithography) as described herein. The metal oxide or silicon dioxide can be deposited at a temperature below the glass transition temperature Tg of polymer microbeads used for nanosphere lithography. The metal oxide can be (e.g., can comprise one or more of) Al2O3, ZnO2, Ta2O5, Nb2O5, SnO2, MgO, indium tin oxide, CeO2, CoO, Co3O4, Cr2O3, Fe2O3, Fe3O4, In2O3, Mn2O3, NiO, a-TiO2 (anatase), r-TiO2 (rutile), WO3, Y2O3, ZrO2, other metal oxides, or combinations thereof. In some embodiments, the metal oxide is transparent to light within a visible wavelength (e.g., from 400 nm to 750 nm).
In the embodiments shown, the one-sided patterned microfluidic devices 200, 201, 202 include patterned nano-wells 240 on a channel floor (e.g., an etched channel floor) surface of the first or top substrate. For example, the top substrate 210 can be first chemically etched to form a channel, and the patterned nano-wells 240 can be formed on the channel floor surface via nanosphere lithography. In some of such embodiments, the bottom substrate 220 is flat and includes two openings from the exterior surface to the interior surface of the bottom substrate 220, one as an inlet port 250 and another as an outlet port 260. The inlet and outlet ports 250, 260 can provide fluidic movement pathways for the microfluidic devices 200, 201, 202. The fluidic movement pathway defines the direction and path of a biological sample passing through a microfluidic device. Specifically, a biological sample can be loaded into a channel of a microfluidic device through its inlet port by a physical force (e.g., pumping). Once loaded, the biological sample can fill up the entire space of the microfluidic channel and come into contact with the top channel floor and bottom surfaces, until the biological sample reaches the outlet port and further exits out of the device. Gene sequencing can include many cycles of reads, each including multiple fluidic exchanges (e.g., nucleotide addition, terminator cleavage, buffer washing).
In some embodiments shown in
In some embodiments, the bonding layer 230 is first patterned on the top substrate 210, followed by protection (e.g., with photoresist or an etchant-resistant polymer tape). After chemical etching, a channel can be formed on the top substrate 210. After nanosphere lithography, patterned nano-well arrays 240 can be formed inside the channel including the channel floor surface. Finally, the protection (e.g., photoresist or polymer tape) can be removed to expose the bonding layer 230. The bonding of the top patterned substrate and the flat bottom substrates 210, 220 can be achieved using a laser-assisted radiation bonding process. In some embodiments, the bonds can be laser bonds, for example, as described in U.S. Pat. Nos. 9,492,990, 9,515,286, and/or 9,120,287, the entirety of which are incorporated herein by reference.
In some embodiments, the bonding layer 230 can comprise a glue, a UV-curable glue, a polymer-carbon black composite film, a double sided pressure adhesive tape, or a double sided polyimide tape. The top substrate 210 can be first partially protected with a photoresist, an ink, or an etchant resistant polymer tape. After chemical etching of the non-protected area to form the channel, nanosphere lithography can be used to form patterned nano-well arrays 240 on the channel floor surface or on individually-addressable channels 105 (see
In some embodiments shown in
In some embodiments shown in
In some embodiments shown in
In some embodiments shown in
In some embodiments shown in
In some embodiments shown in
In some embodiments shown in
In some embodiments shown in
Embodiments of the present disclosure also include a method of making nano-patterned wells on a substrate with or without a channel In some embodiments, the method includes a modified Langmuir-Blodgett-film-type transfer approach. In some embodiments, as shown in
In some embodiments, the method comprises coating the channel interior surfaces of the microfluidic device with a material that enables binding with DNA, proteins, and/or nucleotides to the patterned nano-wells. In some embodiments, the first substrate includes an etched channel before performing nanosphere lithography. In some embodiments, the first substrate includes an etched channel that is further coated with a metal oxide before performing nanosphere lithography. Depending on applications, the resultant nano-wells can have one of the following four possible configurations: bare substrate bottom/SiO2 side wall, bare substrate bottom/metal oxide side wall, metal oxide bottom/SiO2 side wall, or metal oxide bottom/metal oxide side wall. The coating can be one of an organophosphate, a silane, or both, depending on the nano-well configurations and applications. For instance, when the nano-wells formed are metal oxide bottom/SiO2 side wall, an organophosphate that enables binding with DNA, proteins or nucleotides first can be applied to coat the metal oxide bottom, and a silane such as polyethylene glycol silane that is resistant to binding with DNA, proteins, and/or nucleotides then can be used to coat the SiO2 side walls.
The substrate can be a slide, a wafer, a glass sheet, or another suitable configuration. For example, the wafer can be a standard 6 inch wafer, 8 inch wafer, 12 inch wafer, or a square wafer. In some embodiments, the substrate can be flat, or contain etched channels. The dimension of patterned nano-wells on the substrate can be defined by the size of polymer beads before and after the oxygen plasma treatment. The pitch, or center-to-center distance between adjacent nano-wells of patterned nano-wells on the substrate can be defined by the original size of polymer beads. For example, when 1 μm polymer beads are used, the pitch can be about 1 μm. The diameter of the patterned nano-wells can be defined by the size of polymer beads after the oxygen plasma treatment. For example, when the polymer bead size is reduced to 0.5 μm from 1 μm, the diameter of the metal oxide wells can be about 0.5 μm. The depth of the metal oxide or silicon dioxide wells can be defined by the thickness of metal oxide or silicon dioxide film deposited. For example, when a 50 nanometer (nm) layer of metal oxide is deposited, the depth of the metal oxide nano-wells formed can be about 50 nm. In some embodiments, the diameter of the patterned nano-wells obtained using such nanosphere lithography can be further reduced by depositing a layer of metal or silicon oxide film over the entire surface of the patterned substrate using, for example, atomic layer deposition, e-beam deposition, plasma-enhanced chemical vapor deposition, or other approaches.
In some embodiments, oxygen plasma treatment is used to reduce the size of polymer beads. Additionally, or alternatively, argon plasma or other suitable processes can be used to reduce the size of polymer beads. In some embodiments, the size reduction is controlled by three parameters: plasma power, gas flow rate, and/or plasma treatment duration. For instance, in some embodiments shown in
As the plasma treatment duration increased, the polymer bead size was continuously reduced.
Although some embodiments described in reference to
In some embodiments, a monolayer of polymer beads can be formed by pulling a substrate out of a concentrated, well dispersed polymer bead suspension solution after incubation for a certain period of time. In some of such embodiments, the polymer beads can have a negative charge, for instance, carboxylated polystyrene beads; while the substrate can have a positive charge, for instance, the substrate has an aminopropylsilane coating. The electrostatic interaction between the polymer beads and the substrate can enhance the attachment of polymer beads with the substrate surface. Such interaction may result in relatively random distribution of beads on the substrate. By controlling the bead concentration, the solvent, incubation time, pulling rate or the interaction between the beads and the substrate surface, it is possible to form a monolayer of polymer beads on the substrate surface that is well separated and evenly distributed. When this occurs, the plasm treatment may be omitted, and the resulting bead-coated substrate can be directly subjected to oxide film deposition, and the nano-wells can be formed after stripping off the beads.
In some embodiments, the monolayer of polymer beads can be formed on the substrate surface by spin coating of a concentrated, well dispersed polymer bead suspension solution.
The present disclosure also discloses a selective surface chemistry coating of microfluidic devices that include patterned nano-wells on an etched channel floor surface, where the interstitial wall of the nano-wells is made of metal oxide and coated with organophosphate molecules that are resistant to binding with DNA, proteins, and/or nucleotides, and the bottom surface of the nano-wells is made of SiO2 or glass and coated with silane molecules that permit binding to DNA, proteins, and/or nucleotides via either electrostatic interaction or covalent bonds.
The silane molecule used can be aminopropylsilane or the like (e.g., when DNA is DNA nanoballs and attached to the silane coated regions with electrostatic interactions). The silane molecule used can be epoxysilane (e.g., when DNA has an amine terminal so covalent bond can be formed). The silane molecule used can be an aminosilane (e.g., when DNA has an amine terminal and a bifunctional linker molecule (e.g., BS3, or a polymer containing anhydride moieties) is used to covalently couple the DNA to the aminosilane coated regions). The silane molecule used can be a 3-mercaptopropyl trimethoxysilane or the like (e.g., when DNA has a thiol terminal so covalent bond can be formed between DNA and silane molecules). Additionally, or alternatively, the bottom of nano-well surfaces can be coated with an acrylate polymer that permits DNA covalent attachment (e.g., as described in U.S. Patent Pub. No. 2016/0122816A1 (Novel Polymers and DNA Copolymer Coatings), the entirety of which is incorporated herein by reference).
Some embodiments of the present disclosure include a method of using microfluidic devices that include patterned nano-wells on an etched channel floor surface for gene sequencing applications. In some embodiments, a primer DNA sequence (e.g., dA30 or dT30) is covalently or otherwise attached to the bottom regions of metal oxide nano-wells of the substrate, followed by capturing of single-stranded DNA molecules obtained from a sample, clustering generation, and sequencing. The single-stranded DNA molecules obtained from a sample can contain a sequence that is complementary to the primer DNA sequence. The clustering can be performed using bridge amplification, or exclusion amplification, or template walking approaches. The sequencing can be achieved through sequencing by synthesis, or ligation, or single-molecule real-time imaging.
Furthermore, the 8-channel substrate also included a chromium-patterned coating at the top end surfaces of the substrate, beside the channels. After Al2O3 nano-well formation on the entire interior surface of the substrate, the substrate was found to bond with another bottom glass substrate (1×3 inch) using laser assisted bonding at room temperature. The resulting microfluidic device was found to have a hermetic seal and to enable DNA sequencing based on template walking and sequencing by synthesis. Together, these results suggest that the dA30-functionalized microfluidic devices supports massively parallel DNA sequencing.
As disclosed herein, the patterned microfluidic devices can be made of thin and/or channeled substrates, permitting better quality of optical fluorescence imaging of both the top and bottom surfaces of a microfluidic channel due to limited working distance of objectives used for high-resolution imaging. Conventional photolithography and nanoimprinting are typically applicable to patterning on relatively thick flat substrates (e.g., 0.5 mm, 0.7 mm, 1 mm, 1.1 mm). For thinner substrates (e.g., 0.1 mm, 0.2 mm, 0.3 mm), a carrier is typically required for patterning processes. Use of a carrier can complicate the manufacturing process and add cost. In contrast, nanosphere lithography can deal with thinner substrates, or substrates with variable thickness (e.g., channeled substrates).
The patterned microfluidic devices of the present disclosure enable DNA sequencing analysis with high signal-to-background ratios, since the interstitial regions (e.g., between adjacent nano-wells) can be coated with a material resistant to binding with DNA, proteins, and/or nucleotides, and the bottom surface of nano-wells can be coated with a material that promotes binding with DNA, proteins, and/or nucleotides. Additionally, the disclosed processes for manufacturing patterned microfluidic devices can be performed at lower cost compared to conventional photolithography or nanoimprinting techniques, since such processes can be performed without sophisticated and expensive equipment for creating nano-patterning. Furthermore, the disclosed manufacturing processes can be scalable, flexible, and have high throughput. The disclosed processes can be also flexible in terms of substrates, such as flat or channeled substrates, round or square wafers, small (e.g., slides) or large (e.g., wafers, glass sheet) substrates. The disclosed processes can be scalable, since they can be applied to large dimension substrates such as Gen 5 display glass panels. The disclosed processes can readily reach a throughput of several thousand wafers per hour.
All references, including publications, patent applications, and patents cited herein are hereby incorporated by reference to the same extent as if each reference were individually and specifically indicated to be incorporated by reference and were set forth in its entirety herein.
The use of the terms “a” and “an” and “the” and similar referents in the disclosure (especially in the context of the following claims) is to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. The terms “comprising,” “having,” “including,” and “containing” are to be construed as open-ended terms (i.e., meaning “including, but not limited to,”) unless otherwise noted. Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate the disclosed embodiments. No language in the specification should be construed as indicating any non-claimed element as essential.
It will be apparent to those skilled in the art that various modifications and variations can be made without departing from the spirit or scope of the disclosed embodiments. Since modifications, combinations, sub-combinations and variations of the disclosed embodiments incorporating the spirit and substance of the embodiments may occur to persons skilled in the art, the disclosed embodiments should be construed to include everything within the scope of the appended claims and their equivalents.
This application claims the benefit of priority under 35 U.S.C. § 119 of U.S. Provisional Application No. 62/685,100, filed Jun. 14, 2018, the content of which is incorporated herein by reference in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2019/036269 | 6/10/2019 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62685100 | Jun 2018 | US |